HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinibY. Wang, Fred R. Hirsch, Christopher J. Rivard et al.|Annals of Oncology|2018Cited by 217
Early detection of lung cancer by using an autoantibody panel in Chinese populationShengxiang Ren, Fred R. Hirsch, Shucai Zhang et al.|OncoImmunology|2017Cited by 203
Consensus for HER2 alterations testing in non-small-cell lung cancerShengxiang Ren, Fred R. Hirsch, Jiong Wang et al.|ESMO Open|2022Cited by 110
Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8+ T cellsChangsen Leng, Qiu-ming Wang, Yin Li et al.|Oncology Reports|2015Cited by 82
Anti-tumor efficacy of HRS-4642 and its potential combination with proteasome inhibition in KRAS G12D-mutant cancerCaicun Zhou, Shengxiang Ren, Chongyang Li et al.|Cancer Cell|2024Cited by 78